| Literature DB >> 30066293 |
Andrea De Pieri1,2,3, Sofia Ribeiro1,2,4, Dimitrios Tsiapalis1,2, David Eglin5, Marc Bohner6, Peter Dubruel7, Philip Procter8,9, Dimitrios I Zeugolis1,2, Yves Bayon10.
Abstract
The 4th Translational Research Symposium (TRS) was organised at the annual meeting of the European Society for Biomaterials (ESB) 2017, Athens, Greece, with a focus on 'Academia-Industry Clusters of Research for Innovation Catalysis'. Collaborations between research institutes and industry can be sustained in several ways such as: European Union (EU) funded consortiums; syndicates of academic institutes, clinicians and industries; funding from national governments; and private collaborations between universities and companies. Invited speakers from industry and research institutions presented examples of these collaborations in the translation of research ideas or concepts into marketable products. The aim of the present article is to summarize the key messages conveyed during these lectures. In particular, emphasis is put on the challenges to appropriately identify and select unmet clinical needs and their translation by ultimately implementing innovative and efficient solutions achieved through joint academic and industrial efforts.Mesh：
Substances：
Year: 2018 PMID： 30066293 DOI： 10.1007/s10856-018-6136-3
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN： 0957-4530 Impact factor: 3.896